Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research 🏆

Professor at Xiamen University,China 🎓

Dr. Jiaxing Zhang is a distinguished Professor at Xiamen University, specializing in brain hypoxia and its effects on cognitive function and emotions. His research focuses on how the brain adapts and remodels to hypoxia and reoxygenation, exploring neural mechanisms and compensatory regulatory functions in hypoxic conditions. Using advanced techniques such as MRI, molecular biology, and cognitive behavioral testing, Dr. Zhang conducts both human and animal model studies to explore how the brain and cardiovascular systems respond to oxygen deprivation and recovery.

Professional Profile 

Education 🎓:

Dr. Zhang completed his academic training in neuroscience and brain science, earning a Ph.D. that laid the foundation for his pioneering work on brain hypoxia and adaptation mechanisms.

Work Experience 💼:

He is currently a professor at Xiamen University, where he leads research projects focused on brain adaptation to hypoxia, collaborating internationally with other researchers in the field.

Skills 🔍

Dr. Zhang is proficient in advanced research methods, including magnetic resonance imaging (MRI), molecular biology, and cognitive behavioral testing. He also possesses strong interdisciplinary skills in neuroscience and bioengineering.

Awards and Honors 🏆

Dr. Zhang has received numerous recognitions for his scientific contributions, including the Distinguished Scientist Award, which highlights his impactful research on brain adaptation to high-altitude environments.

🤝 Memberships:

He is an active member of various professional scientific communities, contributing to advancements in brain science and hypoxia research.

Teaching Experience 👩‍🏫:

Dr. Zhang has extensive teaching experience, mentoring students and guiding research projects in brain science, neuroscience, and hypoxia adaptation.

Research Focus 🔬:

Dr. Zhang’s research primarily focuses on brain hypoxia and its effects on cognitive function, with a particular interest in high-altitude adaptation. His work provides critical insights into how the brain responds to low-oxygen environments and how these mechanisms can inform health interventions.

Conclusion 

Dr. Fatemeh Rezaei is a highly qualified candidate for the Outstanding Scientist Award. Her achievements in laser and plasma research, especially in laser-based medical applications, position her as a forward-thinking and impactful scientist. With a strong foundation in both education and research, along with meaningful contributions to science and society, Dr. Rezaei exemplifies the qualities of an outstanding scientist. Expanding her publication record and enhancing international collaborations would further amplify her research impact, making her an exceptional choice for this award.

📚 Publilcation 

    1. Correlating EPAS1 gene variations to hypoxic environments with structural and functional brain network adaptations of Tibetans in the Qinghai-Xizang Plateau
      • Year: 2024
      • Journal: Kexue Tongbao/Chinese Science Bulletin
      • Authors: Liu, Y., Fan, C., Zhang, X., Wang, X., Zhang, J.
    2. A longitudinal study on the impact of high-altitude hypoxia on perceptual processes
      • Year: 2024
      • Journal: Psychophysiology
      • Authors: Guo, F., Wang, C., Tao, G., Zhang, J., Wang, Y.
    3. Neuroplasticity of visual brain network induced by hypoxia
      • Year: 2024
      • Journal: Cerebral Cortex
      • Authors: Zhang, X., Liu, Y., Yuan, F., Wang, X., Zhang, J.
    4. Decrease in Cerebral Blood Flow after Reoxygenation Is Associated with Neurological Syndrome Sequelae and Blood Pressure
      • Year: 2023
      • Journal: Brain Sciences
      • Authors: Liu, Y., Yuan, F., Peng, Z., Zhang, R., Zhang, J.
    5. The change of attention network functions and physiological adaptation during high-altitude hypoxia and reoxygenation
      • Year: 2023
      • Journal: Physiology and Behavior
      • Authors: Song, R., Tao, G., Guo, F., Zhang, J., Wang, Y.
    6. Hypoxic White Matter Injury and Recovery After Reoxygenation in Adult Mice: Magnetic Resonance Imaging Findings and Histological Studies
      • Year: 2023
      • Journal: Cellular and Molecular Neurobiology
      • Authors: Liu, Y., Qiao, H., Du, W., Li, S., Zhang, J.
    7. Brain Structural and Functional Alterations in Native Tibetans Living at High Altitude
      • Year: 2023
      • Journal: Neuroscience
      • Authors: Zhang, X., Xie, W., Liu, Y., Ma, H., Zhang, J.
    8. Consistent differences in brain structure and functional connectivity in high-altitude native Tibetans and immigrants
      • Year: 2023
      • Journal: Brain Imaging and Behavior
      • Authors: Zhang, X., Xie, W., Du, W., Ma, H., Zhang, J.
    9. The human brain in a high altitude natural environment: A review
      • Year: 2022
      • Journal: Frontiers in Human Neuroscience
      • Authors: Zhang, X., Zhang, J.
    10. Resting‐State Neuronal Activity and Functional Connectivity Changes in the Visual Cortex after High Altitude Exposure: A Longitudinal Study
    • Year: 2022
    • Journal: Brain Sciences
    • Authors: Zhang, X., Kang, T., Liu, Y., Lin, J., Zhang, J.

Prof. LindaChao | cognitive neuroscience | Best Researcher Award

Prof. LindaChao | cognitive neuroscience | Best Researcher Award 🏆

Professor/Research Career Scientist at UCSF/San Francisco VA Health Care System🎓

Dr. Linda L. Chao is a highly respected neuroscientist whose journey began with a B.S. in Biological Sciences and a Ph.D. in Neuroscience from UC Davis. Following her postdoctoral training as a Cognitive Neuroscience Fellow at the National Institute of Mental Health, Dr. Chao joined UCSF, where she is now a Professor in Radiology, Psychiatry, and Behavioral Sciences. She also contributes significantly to veteran health research at the San Francisco VA Medical Center. Renowned for her expertise in cognitive neuroscience and neuroimaging, Dr. Chao employs advanced MRI, PET, and fMRI techniques to study neurodegenerative diseases, Gulf War Illness, and PTSD. Her groundbreaking work in non-pharmacological therapies for Alzheimer’s and trauma-related conditions has earned her prestigious awards, including the UC Davis Graduate Research Award and the NIMH Fellows Award for Research Excellence. As an active member of key neuroscience organizations and a dedicated mentor, Dr. Chao is a vital figure in advancing mental health research and neuroimaging innovations.

Professional Profile 

Education 🎓:

Dr. Linda L. Chao earned her B.S. in Biological Sciences (1987-1991) and a Ph.D. in Neuroscience (1991-1996) from the University of California, Davis. Her dedication to understanding the brain and its functions began here, paving the way for her groundbreaking work in neuroscience and cognitive research.

 

Work Experience 💼:

Dr. Chao’s career reflects a strong commitment to advancing mental health research. Her postdoctoral training took place at the National Institute of Mental Health (NIMH) as a Cognitive Neuroscience Fellow (1996-2000). She joined the University of California, San Francisco (UCSF) as an Assistant Professor in Radiology and Psychiatry in 2001, advancing to Associate Professor and later Professor in the departments of Radiology & Biomedical Imaging, Psychiatry, and Behavioral Sciences. She also holds a significant role with the San Francisco VA Medical Center, where she contributes to research safety and promotes veteran health.

 

Skills 🔍

Dr. Chao is highly skilled in cognitive neuroscience, neuroimaging, and radiology. She has expertise in analyzing brain health through MRI, PET, and fMRI imaging techniques. Her experience extends to research safety, clinical trials, and therapeutic interventions for neurodegenerative diseases and Gulf War Illness. Her innovative skills in cognitive and neuroimaging research support her work in developing non-pharmacological interventions for conditions like PTSD and Alzheimer’s.

 

Awards and Honors 🏆

Dr. Chao’s research excellence is recognized with numerous awards, including the University of California, Davis Graduate Research Award (1994) and the Fellows Award for Research Excellence from the National Institute of Mental Health (1999). These honors underscore her significant contributions to cognitive neuroscience and clinical research.

 

🤝 Memberships:

Dr. Chao is actively involved in multiple professional organizations, including the Society for Neuroscience (SFN), Cognitive Neuroscience Society (CNS), and the International Society to Advance Alzheimer’s Research and Treatment (ISAART). Her memberships reflect her dedication to staying at the forefront of neuroscience, cognitive health, and clinical research.

Teaching Experience 👩‍🏫:

With a passion for mentoring, Dr. Chao has taught at UCSF’s School of Medicine, facilitating courses on brain, mind, and behavior. She has lectured on clinical fMRI applications and led seminars on neuroimaging. Her role as a mentor has influenced many students and researchers in radiology, psychology, and psychiatry, shaping the future of neuroscience.

 

Research Focus 🔬:

Dr. Chao’s research primarily explores cognitive function, neurodegenerative diseases, and neuroimaging in veterans. Her work on Gulf War Illness and the effects of sarin exposure highlights her commitment to understanding trauma impacts on the brain. Additionally, she investigates photobiomodulation therapies, non-pharmacological dementia treatments, and PTSD interventions. Her recent studies reveal the complex interactions between genetic factors and environmental exposures affecting brain health.

Conclusion 

Dr. Linda L. Chao is a deserving candidate for the Best Researcher Award. Her remarkable contributions to cognitive neuroscience, dedication to mentoring, and commitment to understanding the brain’s response to trauma and neurotoxic exposure make her a vital asset to the field. With her current momentum and slight expansion in her research’s reach and collaboration, Dr. Chao is well-positioned to continue making substantial, globally impactful advancements in neuroscience.

📚 Publilcation 

  • Topic: Implementing a new multidisciplinary, remote, dementia staff training program for Veterans Affairs nursing homes
    • Year: 2024
    • Journal: BMC Health Services Research
  • Topic: Olfactory and cognitive decrements in 1991 Gulf War veterans with Gulf War illness/chronic multisymptom illness
    • Year: 2024
    • Journal: Environmental Health: A Global Access Science Source
  • Topic: Current health status of Gulf War deployed and Gulf War era veterans who use Veterans Affairs health care
    • Year: 2024
    • Journal: Journal of Women’s Health
  • Topic: PON1 status in relation to Gulf War Illness: Evidence of gene–exposure interactions from a multisite case–control study of 1990–1991 Gulf War veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Gulf War illness is associated with host gut microbiome dysbiosis and is linked to altered species abundance in veterans from the BBRAIN cohort
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Livestream, group movement program for people living with cognitive impairment and care partners: A randomized clinical trial
    • Year: 2024
    • Journal: Alzheimer’s and Dementia: Translational Research and Clinical Interventions
  • Topic: Characterizing 1991 Gulf War women veterans from the Boston Biorepository and Integrative Network for Gulf War Illness: Demographics, exposures, neuroimaging, and cognitive outcomes
    • Year: 2024
    • Journal: Clinical Neuropsychologist
  • Topic: Cognitive decrements in 1991 Gulf War veterans: Associations with Gulf War illness and neurotoxicant exposures in the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) cohorts
    • Year: 2023
    • Journal: Environmental Health: A Global Access Science Source

 

Hussein Al-Hakeim | Neuroscience | Best Researcher Award

Prof Hussein Al-Hakeim | Neuroscience | Best Researcher Award 🏆

Peofessor of Medical Biochemistry at University of Kufa, Iraq🎓

 Professor Dr. Hussein Kadhem Al-Hakeim is a distinguished Iraqi academic specializing in Medical Biochemistry, Biological Psychiatry, Insulin Resistance, and Nanobiochemistry. Residing at 28 Al-Adala, Najaf, Iraq, he is currently affiliated with Kufa University. Dr. Al-Hakeim is well-recognized for his significant contributions to biochemistry and clinical chemistry in Iraq.

Professional Profile 

Education🎓

Dr. Al-Hakeim earned his B.Sc. in Chemistry from the University of Mosul in 1991, followed by an M.Sc. in Medical Chemistry and a High Graduate Diploma in Clinical Biochemistry from Al-Nahrain University in 2000 and 2001, respectively. He completed his Ph.D. in Medical Chemistry at the same institution in 2004. Additionally, he holds a Diploma in International Law and Diplomatic Relations from Cairo Regional Center for Training and Arbitration, obtained in 2017.

 💼Work Experience

Dr. Al-Hakeim has held various leadership roles, including Head of the Department of Chemistry at Kufa University and the University of Karbala. He has served as the Assistant Dean and Chief of the Examination Committee at the College of Science, University of Karbala. His teaching career includes extensive experience as a lecturer in postgraduate studies across multiple universities in Iraq.

 🛠️Skills

Dr. Al-Hakeim is an expert in Medical and Clinical Biochemistry, Nanobiochemistry, Insulin Resistance, and Stem Cell Technology. He has a profound knowledge of biostatistics, biosensors, and protein-nanoparticle interactions, and is skilled in advanced laboratory techniques and various biochemical analysis methods.

 🏆Awards and Honors

Dr. Al-Hakeim’s work has been recognized at numerous scientific congresses and conferences worldwide. His research contributions and academic leadership have earned him a prominent place in Iraq’s scientific community.

 Membership 🏛️and Affiliations 🤝

Dr. Al-Hakeim is an active member of several scientific committees and associations. He frequently participates in international conferences and has presented his research at numerous prestigious events.

 Teaching Experience👨‍🏫

Dr. Al-Hakeim has taught a wide range of courses at the B.Sc., M.Sc., and Ph.D. levels. His subjects include Advanced Biochemistry, Clinical Biochemistry, Toxicology, Endocrinology, Biostatistics, and more. He has also coordinated several courses and training programs, contributing significantly to the academic development of his students.

 Research Focus 🔬

Dr. Al-Hakeim’s research interests encompass Medical Biochemistry, Clinical Chemistry, Insulin Resistance Mechanisms, Stem Cell Technology, Nanobiochemistry, and the Medical Applications of Surface Chemistry. His work is particularly focused on protein-nanoparticle interactions, a field where he has made substantial contributions.

📖Publications : 

  • IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
    • 🗓️ Year: 2015
    • 📚 Journal: Journal of Affective Disorders
  • Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses, and inflammation: a proof of concept
    • 🗓️ Year: 2023
    • 📚 Journal: Molecular Psychiatry
  • Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
    • 🗓️ Year: 2011
    • 📚 Journal: Asian Journal of Transfusion Science
  • Intersections between pneumonia, lowered oxygen saturation percentage, and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID
    • 🗓️ Year: 2021
    • 📚 Journal: Journal of Affective Disorders
  • The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
    • 🗓️ Year: 2022
    • 📚 Journal: Molecular Psychiatry
  • The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
    • 🗓️ Year: 2022
    • 📚 Journal: medRxiv
  • Serum levels of lipids, calcium, and magnesium in women with hypothyroidism and cardiovascular diseases
    • 🗓️ Year: 2009
    • 📚 Journal: Journal of Laboratory Physicians
  • High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and…
    • 🗓️ Year: 2020
    • 📚 Journal: Schizophrenia Bulletin
  • IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder
    • 🗓️ Year: 2019
    • 📚 Journal: European Psychiatry
  • Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision…
    • 🗓️ Year: 2023
    • 📚 Journal: Acta Neuropsychiatrica
  • The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with…
    • 🗓️ Year: 2023
    • 📚 Journal: Journal of Affective Disorders
  • Serum interleukin levels and insulin resistance in major depressive disorder
    • 🗓️ Year: 2018
    • 📚 Journal: CNS & Neurological Disorders – Drug Targets
  • Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation, and neuroimmunotoxic pathways
    • 🗓️ Year: 2022
    • 📚 Journal: International Journal of Environmental Research and Public Health
  • Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity…
    • 🗓️ Year: 2020
    • 📚 Journal: CNS Spectrums
  • The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
    • 🗓️ Year: 2022
    • 📚 Journal: Brain, Behavior, & Immunity – Health
  • The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study
    • 🗓️ Year: 2020
    • 📚 Journal: Neurotoxicity Research
  • Serum apelin and galectin-3 in preeclampsia in Iraq
    • 🗓️ Year: 2020
    • 📚 Journal: Hypertension in Pregnancy
  • Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
    • 🗓️ Year: 2020
    • 📚 Journal: Current Topics in Medicinal Chemistry
  • Estimation of Serum Copper, Manganese, Selenium, and Zinc in Hypothyroidism Patients
    • 🗓️ Year: 2009
    • 📚 Journal: IUFS Journal of Biology
  • Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate, iron overload, and increased pro…
    • 🗓️ Year: 2020
    • 📚 Journal: Neurotoxicity Research

Marjan Shariatpanahi | Neuroscience | Best Researcher Award

Dr Marjan Shariatpanahi |  Neuroscience | Best Researcher Award 

Associate professor at Iran university of medical sciences,Iran

Dr. Marjan Shariatpanahi is an Associate Professor in the Department of Pharmacology and Toxicology at the School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. With extensive experience in toxicology and pharmacology, Dr. Shariatpanahi has made significant contributions to research on neurodegenerative diseases and toxicology.

professional profile

scopus

google scholar

Education 🎓

Dr. Shariatpanahi holds a Doctor of Pharmacy (Pharm. D.) from Islamic Azad University, Tehran (2000-2006) with a thesis on thymidine phosphorylase and estrogen receptor alpha in colorectal cancer. She also earned a Ph.D. in Toxicology from Tehran University of Medical Sciences (2009-2014), focusing on the effects of PKG on spatial memory deficits and markers of autophagy and apoptosis in rats.

Work Experience 🏥

Dr. Shariatpanahi has a diverse professional background. She has been the Head of the Pharmacology & Toxicology Department at Iran University of Medical Sciences since 2017. Her previous roles include Dean of the Educational Office (2020-2023), Head of Student and Cultural Affairs (2019-2020), and faculty member at the Neuroscience Research Center (2018-present). She has also worked as an Assistant Professor at both Iran University of Medical Sciences and Guilan University of Medical Sciences, and as a Responsible Pharmacist in various institutions.

Skills 🛠️

Dr. Shariatpanahi is proficient in various research techniques, including IHC, Western blot, ICC, in vivo studies, and behavioral tests for neurodegenerative diseases. Her expertise extends to TLC, spectrophotometry, SPSS, PRISM, ELISA, and gas chromatography. She is also skilled in using atomic absorption machines and Endnote.

Awards and Honors 🏅

Dr. Shariatpanahi has received several accolades, including being named the best professor at the Vosough Festival of IUMS (2023) and being recognized as a selected pharmacist (2022). She was also acknowledged as a top student in toxicology and pharmacy, receiving first ranks in board examinations and seminars.

Professional Memberships 🔗

Dr. Shariatpanahi is a member of the Iranian Association of Toxicology, the Iranian Medical Council, the Iranian Association of Pharmacists, the Iranian Probiotics Society, and the Talent Society of Tehran University.

Teaching Experience 📚

Dr. Shariatpanahi has taught a wide range of courses across various levels. For Ph.D. students, she covers basics of pharmacology. For Doctor of Pharmacy students, she teaches toxicology, pharmacology, clinical toxicology, and specialized pharmacy language. Her M.Sc. teaching includes environmental toxicology, forensic toxicology, and advanced research methods, while for B.Sc. students, she focuses on toxicology.

Research Focus 🔬

Dr. Shariatpanahi’s research interests include neuroscience, with a focus on autism, Alzheimer’s disease, memory, and Parkinson’s disease. She is also involved in toxicology, environmental toxicology, pharmacology, cell signaling, stem cell therapy, and the study of behavioral investigations on animals. Her work explores various markers and mechanisms in carcinogenesis, angiogenesis, and the protective and toxic effects of nanoparticles.

Conclusion

Dr. Marjan Shariatpanahi’s extensive qualifications, leadership roles, significant research contributions, and recognition in the field make him an excellent candidate for the Best Researcher Award. His achievements demonstrate a strong commitment to advancing knowledge in pharmacology and toxicology, contributing valuable insights into neurodegenerative diseases, toxicology, and pharmacology.

publication 

 

Amit Chougule | Cognitive Neuroscience | Best Researcher Award

Mr Amit Chougule | Cognitive Neuroscience | Best Researcher Award

 

Researcher at Manentia AI, India

 

 

📚 Amit Chougule is a distinguished deep learning and AI researcher with a PhD from BITS Pilani, dedicated to advancing AI through cutting-edge research, algorithm development, and impactful industry contributions. He has over 3 years of expertise in AI and Computer Vision, having worked with esteemed organizations like Philips Research, Sony Research India, and Carleton University’s TrustCAV Research. Amit is proficient in Python and skilled in utilizing various libraries for data manipulation, statistical analysis, and machine learning. His experience includes designing end-to-end AI solutions and developing models for healthcare, autonomous vehicles, and more. 🚀🤖📊

Professional Profile:

 

🎓 Education:

  • PhD in Computer Vision & AI, BITS Pilani, Pilani (2021-2024)
    • Thesis: Artificial Intelligence Enabled Vehicular Vision and Service Provisioning for Advanced Driver Assistance Systems (ADAS)
    • Supervisors: Dr. Vinay Chamola, Dr. Pratik Narang & Prof. F. Richard Yu (IEEE Fellow)
  • M.Tech in Big Data & IoT, PES University, Bengaluru (2018-2020)
    • Specializations: IoT, Cloud Computing, Big Data & Cyber Security
  • B.Tech in Computer Engineering, Shivaji University (2013-2017)
    • Focus Areas: Computer Algorithm, Data Structure, Computer Networks & Operating System

💼 Experience:

  • Visiting Researcher, Carleton University, Canada (Dec 2022 – June 2023)
    • Developed techniques for enhancing self-driving vehicles.
    • Analyzed the impact of abnormal weather on vision-based autonomous vehicle operations.
    • Introduced a computer vision-based attention model for reliable autonomous driving in adverse weather.
  • Computer Vision Intern (PhD), Sony Research (Oct 2022 – Nov 2022)
    • Innovated a computer vision model for diagnosing diseases using biomarkers.
    • Developed an advanced pipeline for predicting diseases based on anatomical biomarkers.
  • Machine Learning Engineer, AIvolved Technologies (Aug 2020 – Dec 2020)
    • Worked on object detection, tracking, pose estimation, and web scraping for applications like gait analysis and traffic analysis.
  • Computer Vision Intern, Philips Healthcare Research (July 2019 – July 2020)
    • Conducted research on ultrasound medical imaging.
    • Developed an Anatomical Intelligent Fetal Heart Ultrasound Scanning technique.
    • Implemented an AI model for precise estimation of fetal femur length.

🔧 Skills:

  • Programming Languages: C, C++, JAVA, Python, SQL
  • Machine Learning Frameworks: PyTorch, Keras, TensorFlow
  • CI/CD Tools: Git
  • MLOps Frameworks and Tools: Docker, Kubernetes
  • Data Pipelines and Analytics Tools: Apache Spark, PySpark
  • Image Processing: OpenCV, Matplotlib, Scikit-image, SciPy, Pillow
  • Generative AI: Autoencoders, GANs, Diffusion Models
  • Computer Vision Domains: Image Classification, Object Detection, Object Tracking, Segmentation, Pose Estimation, Computational Geometry, Image Generation
  • Medical Imaging Tools: ImageJ, 3D Slicer, OsiriX, SimpleITK, ITK-SNAP, RadiAnt DICOM
  • Hardware: Arduino, Raspberry Pi, Nvidia Jetson Nano

🏆 Awards and Honors:

  1. Generative Adversarial Networks (GANs) Specialization by Coursera
  2. Deep Learning with Numpy by Udemy
  3. Getting Started with AWS Machine Learning by Amazon (Coursera)
  4. Computer Vision Basics by University at Buffalo and The State University of New York (Coursera)
  5. Digital Image Processing with OpenCV in Python by GEO University
  6. Data Science with Python by Pluralsight
  7. Pandas Foundations by Datacamp
  8. Python (Advanced Level) by HackerRank

🔬 Research Focus:

Amit Chougule is dedicated to advancing artificial intelligence through cutting-edge research, innovative algorithm development, and impactful industry contributions. He focuses on:

  • Deep Learning Technology: Solving complex real-world problems and driving societal impact.
  • Computer Vision: Enhancing autonomous vehicle capabilities, especially in adverse weather conditions.
  • Medical Imaging: Developing AI models for accurate disease diagnosis and fetal growth prediction.
  • AI Solutions: Designing end-to-end AI solutions, from data pipeline architecture to model deployment.

Publications: